Dissecting Roles of Ubiquitination in the p53 Pathway

Conference paper
Part of the Ernst Schering Foundation Symposium Proceedings book series (SCHERING FOUND, volume 2008/1)


Posttranslational modification of proteins by mono- or polyubiquitination represents a central mechanism to modulate a wide range of cellular functions like protein stability, intracellular transport, protein interactions, and transcriptional activity. Analogous to other posttranslational modifications, ubiquitination is a reversible process counteracted by deubiquitinating enzymes (DUBs), which cleave the isopeptide linkage between protein substrate and the ubiquitin residue. The p53 tumor suppressor is a sequence-specific DNA-binding transcriptional factor that plays a central role in regulating growth arrest and apoptosis during the stress response. Notably, recent studies indicate that both the stability and the subcellular localization of p53 are tightly regulated by ubiquitination; p53 is mainly ubiquitinated by Mdm2 but other ubiquitin ligases such as ARF-BP1/HectH9/MULE are also involved in p53 regulation in vivo. Moreover, a deubiquitinase HAUSP was initially identified in p53 deubiquitination but more recent studies showed that both Mdm2 and Mdmx are also bona fide substrates of HAUSP. In this article, we review our latest understanding of ubiquitination in modulating the p53 tumor suppression pathway.


Ubiquitin Ligase Nuclear Export Tumor Suppressor Function Cell Growth Arrest Deubiquitination Enzyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The research in Wei Gu's lab is supported in part by grants from NIH/NCI, Leukemia and Lymphoma Society, and Ellison Medical Foundation.


  1. Amerik AY, Hochstrasser M (2004) Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 1695:189–207CrossRefPubMedGoogle Scholar
  2. Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15:164–171CrossRefPubMedGoogle Scholar
  3. Brooks CL, Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21:307–315Google Scholar
  4. Brooks C, Shi Y, Li M, Gu W (2007) The p53-Mdm2-HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene 26:7262–7266CrossRefPubMedGoogle Scholar
  5. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W (2005) ARF-BP1 is a critical mediator of the ARF tumor suppressor. Cell 121:1071–83CrossRefPubMedGoogle Scholar
  6. Cummins JM, Vogelstein B (2004) HAUSP is required for p53 destabilization. Cell Cycle 3:689–692CrossRefPubMedGoogle Scholar
  7. D'Andrea A, Pellman D (1998) Deubiquitinating enzymes: a new class of biological regulators. Crit Rev Biochem Mol Biol 33:337–352CrossRefPubMedGoogle Scholar
  8. Hicke L, Dunn R (2003) Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol 19:141–172CrossRefPubMedGoogle Scholar
  9. Hu M, Li P, Li M, Li W, Yao T, Wu J-W, Gu W, Cohen RE, Shi Y (2002) Crystal structure of a UBP-family deubiquiting enzyme: in isolation and in complex with ubiquitin aldehyde Cell 111:1041–1054Google Scholar
  10. Hu M, Li M, Gu H, Jeffrey PD, Gu W, Shi Y (2006) Structural basis of competitive recognition of p53 and Mdm2 by HAUSP: implications for the p53/Mdm2 pathway. PLoS Biol 4:228–239CrossRefGoogle Scholar
  11. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416:648–653CrossRefPubMedGoogle Scholar
  12. Li M, Chris B, Wu-Baer F, Chen D, Bear R, Gu W (2003) Mono- vs. polyubiquitination: differential control of p53 fate by Mdm2. Science 302:1972–1975CrossRefPubMedGoogle Scholar
  13. Li M, Brooks CL, Kon N, Gu W (2004) A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 13:879–886CrossRefPubMedGoogle Scholar
  14. Lowe SW, Sherr CJ (2003) Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13:77–83CrossRefPubMedGoogle Scholar
  15. Meulmeester E, Maurice MM, Boutel C et al (2005) Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Molecular cell 18:565–576CrossRefPubMedGoogle Scholar
  16. Michael D, Oren M (2003) The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13:49–58CrossRefPubMedGoogle Scholar
  17. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123:773–786CrossRefPubMedGoogle Scholar
  18. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112–126CrossRefPubMedGoogle Scholar
  19. Russell NS, Wilkinson KD (2005) Deubiquitinating enzyme purification, assay inhibitors, and characterization. Methods Mol Biol 301:207–219PubMedGoogle Scholar
  20. Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6:663–673CrossRefPubMedGoogle Scholar
  21. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310CrossRefPubMedGoogle Scholar
  22. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275–283CrossRefPubMedGoogle Scholar
  23. Zhong Q, Gao W, Du F, Wang X (2005) Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121:1085–1095CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Institute for Cancer Genetics and Department of Pathology and Cell BiologyCollege of Physicians and SurgeonsNew YorkUSA
  2. 2.Institute for Cancer Genetics and Department of Radiation OncologyCollege of Physicians and SurgeonsNew YorkUSA

Personalised recommendations